Form 8-K - Current report:
SEC Accession No. 0001104659-21-058250
Filing Date
2021-04-30
Accepted
2021-04-30 08:01:36
Documents
3
Period of Report
2021-04-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2114596d1_8k.htm 8-K 22042
2 EXHIBIT 99.1 tm2114596d1_ex99-1.htm EX-99.1 11818
3 GRAPHIC image_004.jpg GRAPHIC 2598
  Complete submission text file 0001104659-21-058250.txt   38913
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34058 | Film No.: 21873823
SIC: 2834 Pharmaceutical Preparations